Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
An overview of new GLP-1 receptor agonists for type 2 diabetes
HTML
Details
Locations
Year:
2015
Type:
review
Source:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.2016.1123249
Authors:
Brian Tomlinson,
Miao Hu,
Yuzhen Zhang,
Paul Chan,
Zhong-Min Liu
Institutions:
Tongji University,
Chinese University of Hong Kong,
Prince of Wales Hospital,
Shanghai East Hospital,
Wan Fang Hospital,
Taipei Medical University
show all 6
Language:
English
Topic:
Diabetes Treatment and Management
Subfield:
Endocrinology, Diabetes and Metabolism
Field:
Medicine
Domain:
Health Sciences
Keywords:
GLP-1 receptor agonists,
type 2 diabetes,
oral GLP-1 receptor agonists,
subcutaneous dosing,
weight loss,
cardiovascular outcome trials,
lixisenatide,
empagliflozin,
SGLT2 inhibitors,
DPP-4 inhibitors,
drug development
show all 11
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2257678016
FWCI:
1.053
Cites:
106
Cited by:
52
Related to:
10